886366-98-9 Usage
Uses
Used in Pharmaceutical Industry:
2-Thiazolecarboxylic acid,4-[4-(trifluoromethyl)phenyl]is utilized as a building block for the synthesis of pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Development:
2-Thiazolecarboxylic acid,4-[4-(trifluoromethyl)phenyl]also has potential use in the creation of agrochemicals, where its specific chemical properties could be leveraged to develop new products for agricultural applications.
Used in Specialty Chemicals:
2-Thiazolecarboxylic acid,4-[4-(trifluoromethyl)phenyl]may be employed in the production of specialty chemicals, where its distinctive attributes can contribute to the advancement of various chemical products.
Further Research:
Additional research is necessary to fully explore the properties and potential applications of 2-Thiazolecarboxylic acid,4-[4-(trifluoromethyl)phenyl]-, ensuring its safe and effective use across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 886366-98-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,3,6 and 6 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 886366-98:
(8*8)+(7*8)+(6*6)+(5*3)+(4*6)+(3*6)+(2*9)+(1*8)=239
239 % 10 = 9
So 886366-98-9 is a valid CAS Registry Number.
886366-98-9Relevant academic research and scientific papers
Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides as potent and selective dipeptidyl peptidase IV inhibitors
Nitta, Aiko,Fujii, Hideaki,Sakami, Satoshi,Satoh, Mikiya,Nakaki, Junko,Satoh, Shiho,Kumagai, Hiroki,Kawai, Hideki
, p. 7036 - 7040 (2013/01/15)
A series of novel 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides were investigated as dipeptidyl peptidase IV (DPP-4) inhibitors. Introduction of a 4-phenylthiazol-2-yl group showed highly potent DPP-4 inhibitory activity. Among various derivatives, (3R)-3-amino-N-(4-(4-phenylthiazol-2-yl)-tetrahydro-2H- thiopyran-4-yl)-4-(2,4,5-trifluorophenyl)butanamide 1,1-dioxide (30) reduced blood glucose excursion in an oral glucose tolerance test by oral administration.
COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS
-
Page/Page column 25-26, (2008/06/13)
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families.
